
Medicine and Health
Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study
C. Zheng, H. Lu, et al.
This groundbreaking study by Chuansheng Zheng and colleagues highlights the superior efficacy and safety of combining transarterial chemoembolization (TACE) with sunitinib in treating advanced renal cell carcinoma, showcasing remarkable improvements in response rates and survival outcomes.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.